{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T12:32:12Z","timestamp":1781008332427,"version":"3.54.1"},"reference-count":201,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.intimp.2023.109699","type":"journal-article","created":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T11:19:07Z","timestamp":1677669547000},"page":"109699","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Dysregulated balance in Th17\/Treg axis of Pristane-induced lupus mouse model, are mesenchymal stem cells therapeutic?"],"prefix":"10.1016","volume":"117","author":[{"given":"Akram","family":"Hoseinzadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8731-7999","authenticated-orcid":false,"given":"Zahra","family":"Rezaieyazdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Mahmoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalil","family":"Tavakol Afshari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahimeh","family":"Lavi Arab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9371-4170","authenticated-orcid":false,"given":"Seyed-Alireza","family":"Esmaeili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arezoo","family":"Faridzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin","family":"Rezaeian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Hoseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Barati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Mahmoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nafiseh","family":"Sadat Tabasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.intimp.2023.109699_b0005","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1177\/0300985810370005","article-title":"Mouse models of systemic lupus erythematosus reveal a complex pathogenesis","volume":"47","author":"Rottman","year":"2010","journal-title":"Vet. Pathol."},{"issue":"2","key":"10.1016\/j.intimp.2023.109699_b0010","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.autrev.2017.11.016","article-title":"Curcumin: A natural modulator of immune cells in systemic lupus erythematosus","volume":"17","author":"Momtazi-Borojeni","year":"2018","journal-title":"Autoimmun. Rev."},{"issue":"8","key":"10.1016\/j.intimp.2023.109699_b0015","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1002\/jcp.25748","article-title":"Tolerogenic probiotics: potential immunoregulators in systemic lupus erythematosus","volume":"232","author":"Esmaeili","year":"2017","journal-title":"J. Cell. Physiol."},{"issue":"8","key":"10.1016\/j.intimp.2023.109699_b0020","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1093\/ndt\/gfaa117","article-title":"Long-term effects of combined B-cell immunomodulation with rituximab and belimumab in severe, refractory systemic lupus erythematosus: 2-year results","volume":"36","author":"Kraaij","year":"2021","journal-title":"Nephrol. Dial. Transplant."},{"issue":"3","key":"10.1016\/j.intimp.2023.109699_b0025","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2478\/acb-2021-0016","article-title":"Mesenchymal stem cells and their secretome-candidates for safe and effective therapy for systemic lupus erythematosus","volume":"9","author":"Popis","year":"2021","journal-title":"Medical Journal of Cell Biology"},{"issue":"1","key":"10.1016\/j.intimp.2023.109699_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00005-021-00603-y","article-title":"Functional Characteristics and Application of Mesenchymal Stem Cells in Systemic Lupus Erythematosus","volume":"69","author":"Tang","year":"2021","journal-title":"Arch. Immunol. Ther. Exp. (Warsz.)"},{"key":"10.1016\/j.intimp.2023.109699_b0035","unstructured":"Esmaeili, S.A., Evaluation of Vitamin D3 deficiency in random population in north east of Iran between 2015-2016.."},{"key":"10.1016\/j.intimp.2023.109699_b0040","series-title":"Induction of autoimmunity by adjuvant hydrocarbons. Infection and autoimmunity","first-page":"87","author":"Kelly","year":"2004"},{"issue":"11","key":"10.1016\/j.intimp.2023.109699_b0045","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1007\/s10067-017-3811-6","article-title":"Pristane-induced lupus: considerations on this experimental model","volume":"36","author":"Freitas","year":"2017","journal-title":"Clin. Rheumatol."},{"issue":"10","key":"10.1016\/j.intimp.2023.109699_b0050","doi-asserted-by":"crossref","first-page":"e0164423","DOI":"10.1371\/journal.pone.0164423","article-title":"Pristane-accelerated autoimmune disease in (SWR X NZB) F1 mice leads to prominent tubulointerstitial inflammation and human lupus nephritis-like fibrosis","volume":"11","author":"Gardet","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.intimp.2023.109699_b0055","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.stemcr.2018.01.029","article-title":"A long-term follow-up study of allogeneic mesenchymal stem\/stromal cell transplantation in patients with drug-resistant systemic lupus erythematosus","volume":"10","author":"Wang","year":"2018","journal-title":"Stem Cell Rep."},{"issue":"2","key":"10.1016\/j.intimp.2023.109699_b0060","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrrheum.2013.157","article-title":"Pragmatic approaches to therapy for systemic lupus erythematosus","volume":"10","author":"Xiong","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"issue":"9894","key":"10.1016\/j.intimp.2023.109699_b0065","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0140-6736(13)60889-2","article-title":"Systemic lupus erythematosus and other autoimmune rheumatic diseases: challenges to treatment","volume":"382","author":"Murphy","year":"2013","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.intimp.2023.109699_b0070","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000513741","article-title":"An update for mesenchymal stem cell therapy in lupus nephritis","volume":"7","author":"Li","year":"2021","journal-title":"Kidney Diseases"},{"key":"10.1016\/j.intimp.2023.109699_b0075","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.lfs.2018.12.018","article-title":"Molecular mechanism involved in cyclophosphamide-induced cardiotoxicity: Old drug with a new vision","volume":"218","author":"Iqubal","year":"2019","journal-title":"Life Sci"},{"issue":"4","key":"10.1016\/j.intimp.2023.109699_b0080","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1080\/15476278.2015.1126018","article-title":"Mesenchymal stem cells: potential for therapy and treatment of chronic non-healing skin wounds","volume":"11","author":"Marfia","year":"2015","journal-title":"Organogenesis"},{"key":"10.1016\/j.intimp.2023.109699_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102491","article-title":"Human gingiva-derived mesenchymal stem cells are therapeutic in lupus nephritis through targeting of CD39\u2212 CD73 signaling pathway","volume":"113","author":"Dang","year":"2020","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.intimp.2023.109699_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2019.03.016","article-title":"Cardioprotective microRNAs: Lessons from stem cell-derived exosomal microRNAs to treat cardiovascular disease","volume":"285","author":"Moghaddam","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.intimp.2023.109699_b0095","first-page":"9","article-title":"Current advanced therapies based on human mesenchymal stem cells for skin diseases","author":"Sierra-S\u00e1nchez","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.intimp.2023.109699_b0100","first-page":"1","article-title":"Cross Talk between Mesenchymal Stem\/Stromal Cells and Innate Immunocytes Concerning Lupus Disease","author":"Mahmoudi","year":"2022","journal-title":"Stem Cell Rev. Rep."},{"key":"10.1016\/j.intimp.2023.109699_b0105","series-title":"Mesenchymal stem cells modulate the immune system in developing therapeutic interventions","author":"Rawat","year":"2019"},{"issue":"1","key":"10.1016\/j.intimp.2023.109699_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-018-0898-x","article-title":"Genetic contribution to mesenchymal stem cell dysfunction in systemic lupus erythematosus","volume":"9","author":"Zhu","year":"2018","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.intimp.2023.109699_b0115","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3389\/fcell.2019.00285","article-title":"Mesenchymal stem cells: allogeneic MSC may be immunosuppressive but autologous MSC are dysfunctional in lupus patients","author":"Cheng","year":"2019","journal-title":"Front. Cell Dev. Biol."},{"issue":"5","key":"10.1016\/j.intimp.2023.109699_b0120","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.3390\/cells9051145","article-title":"Identifying the therapeutic significance of mesenchymal stem cells","volume":"9","author":"Mishra","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.intimp.2023.109699_b0125","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/978-1-62703-511-8_10","article-title":"Immune responses after mesenchymal stem cell implantation","author":"Atoui","year":"2013","journal-title":"Cellular Cardiomyoplasty"},{"key":"10.1016\/j.intimp.2023.109699_b0130","first-page":"112","article-title":"Interplay between mesenchymal stromal cells and immune system: Clinical applications in immune-related diseases","volume":"1","author":"Mallis","year":"2021","journal-title":"Explor. Immunol"},{"issue":"12","key":"10.1016\/j.intimp.2023.109699_b0135","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.4252\/wjsc.v12.i12.1529","article-title":"Mesenchymal stem cells secretome: The cornerstone of cell-free regenerative medicine","volume":"12","author":"Gonz\u00e1lez-Gonz\u00e1lez","year":"2020","journal-title":"World journal of stem cells"},{"key":"10.1016\/j.intimp.2023.109699_b0140","doi-asserted-by":"crossref","unstructured":"Crisp\u00edn, J.C., et al. t cells as therapeutic targets in systemic lupus erythematosus. 2010.","DOI":"10.1155\/2010\/943254"},{"issue":"4","key":"10.1016\/j.intimp.2023.109699_b0145","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/08916934.2017.1300884","article-title":"Annexin A1 as a target for managing murine pristane-induced systemic lupus erythematosus","volume":"50","author":"Mihaylova","year":"2017","journal-title":"Autoimmunity"},{"issue":"3","key":"10.1016\/j.intimp.2023.109699_b0150","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s10067-016-3197-x","article-title":"Vitamin A improve Th17 and Treg regulation in systemic lupus erythematosus","volume":"35","author":"Handono","year":"2016","journal-title":"Clin. Rheumatol."},{"issue":"2","key":"10.1016\/j.intimp.2023.109699_b0155","doi-asserted-by":"crossref","first-page":"540","DOI":"10.4049\/jimmunol.1400931","article-title":"IL-17 promotes murine lupus","volume":"193","author":"Amarilyo","year":"2014","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2023.109699_b0160","doi-asserted-by":"crossref","first-page":"17","DOI":"10.21315\/mjms2018.25.3.3","article-title":"Regulatory T cells compensation failure cause the dysregulation of immune response in pristane induced lupus mice model","volume":"25","author":"Kalim","year":"2018","journal-title":"The Malaysian Journal of Medical Sciences: MJMS"},{"issue":"4","key":"10.1016\/j.intimp.2023.109699_b0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar4277","article-title":"Clinical associations of serum interleukin-17 in systemic lupus erythematosus","volume":"15","author":"Vincent","year":"2013","journal-title":"Arthritis Res. Ther."},{"issue":"6","key":"10.1016\/j.intimp.2023.109699_b0170","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.immuni.2012.08.014","article-title":"Interleukin-17 cytokines are critical in development of fatal lupus glomerulonephritis","volume":"37","author":"Pisitkun","year":"2012","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.intimp.2023.109699_b0175","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.cyto.2014.12.027","article-title":"Th1\/Th2\/Th17\/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity","volume":"72","author":"Talaat","year":"2015","journal-title":"Cytokine"},{"issue":"9","key":"10.1016\/j.intimp.2023.109699_b0180","first-page":"1342","article-title":"Pristane induced arthritis in mice. IV. Immunotherapy with monoclonal antibodies directed against lymphocyte subsets","volume":"19","author":"Levitt","year":"1992","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.intimp.2023.109699_b0185","doi-asserted-by":"crossref","unstructured":"Satoh, M., et al., Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB\/c mice treated with pristane. Proceedings of the National Academy of Sciences, 1995. 92(24): p. 10934-10938.","DOI":"10.1073\/pnas.92.24.10934"},{"issue":"5","key":"10.1016\/j.intimp.2023.109699_b0190","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.4049\/jimmunol.1300341","article-title":"Overexpression of membrane-bound fas ligand (CD95L) exacerbates autoimmune disease and renal pathology in pristane-induced lupus","volume":"191","author":"Bossaller","year":"2013","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2023.109699_b0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar1824","article-title":"Association between occupational exposure to mineral oil and rheumatoid arthritis: results from the Swedish EIRA case\u2013control study","volume":"7","author":"Sverdrup","year":"2005","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.intimp.2023.109699_b0200","first-page":"1","article-title":"Cluster of systemic lupus erythematosus (SLE) associated with an oil field waste site: a cross sectional study","volume":"6","author":"Dahlgren","year":"2007","journal-title":"Environ. Health"},{"key":"10.1016\/j.intimp.2023.109699_b0205","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.biopha.2018.04.147","article-title":"Analysis of Th22, Th17 and CD4+ cells co-producing IL-17\/IL-22 at different stages of human colon cancer","volume":"103","author":"Doulabi","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"7","key":"10.1016\/j.intimp.2023.109699_b0210","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1089\/dna.2005.24.458","article-title":"Effects of allogeneic bone marrow-derived mesenchymal stem cells on T and B lymphocytes from BXSB mice","volume":"24","author":"Deng","year":"2005","journal-title":"DNA Cell Biol."},{"issue":"8","key":"10.1016\/j.intimp.2023.109699_b0215","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1002\/1529-0131(199908)42:8<1644::AID-ANR12>3.0.CO;2-L","article-title":"Th1\/Th2 balance of peripheral T helper cells in systemic lupus erythematosus","volume":"42","author":"Akahoshi","year":"1999","journal-title":"Arthritis & Rheumatism: Official Journal of the American College of Rheumatology"},{"issue":"8","key":"10.1016\/j.intimp.2023.109699_b0540","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1002\/art.27548","article-title":"Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus","volume":"62","author":"Sun","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.intimp.2023.109699_b0220","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.clim.2011.08.005","article-title":"Disturbed Th1, Th2, Th17 and Treg balance in patients with systemic lupus erythematosus","volume":"141","author":"Dolff","year":"2011","journal-title":"Clin. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2023.109699_b0225","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1006\/clin.1996.0118","article-title":"Short analytical review Thl and Th2 in human diseases","volume":"80","author":"Sergio","year":"1996","journal-title":"Clin. Immunol. Immunopathol."},{"issue":"6","key":"10.1016\/j.intimp.2023.109699_b0230","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/0952-7915(95)80050-6","article-title":"The Th1\/Th2 balance in autoimmunity","volume":"7","author":"Charlton","year":"1995","journal-title":"Curr. Opin. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2023.109699_b0235","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/stem.68","article-title":"Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans","volume":"27","author":"Sun","year":"2009","journal-title":"Stem Cells"},{"issue":"1","key":"10.1016\/j.intimp.2023.109699_b0240","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nprot.2008.221","article-title":"A protocol for isolation and culture of mesenchymal stem cells from mouse bone marrow","volume":"4","author":"Soleimani","year":"2009","journal-title":"Nat. Protoc."},{"issue":"6","key":"10.1016\/j.intimp.2023.109699_b0245","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/jcb.10594","article-title":"Characterization of mesenchymal stem cells isolated from murine bone marrow by negative selection","volume":"89","author":"Baddoo","year":"2003","journal-title":"J. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.intimp.2023.109699_b0250","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.apsb.2016.07.001","article-title":"Salvianolic acid A alleviates renal injury in systemic lupus erythematosus induced by pristane in BALB\/c mice","volume":"7","author":"Lin","year":"2017","journal-title":"Acta Pharm. Sin. B"},{"issue":"8","key":"10.1016\/j.intimp.2023.109699_b0255","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1177\/0961203313492869","article-title":"Pristane-induced lupus as a model of human lupus arthritis: evolvement of autoantibodies, internal organ and joint inflammation","volume":"22","author":"Leiss","year":"2013","journal-title":"Lupus"},{"issue":"13","key":"10.1016\/j.intimp.2023.109699_b0260","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1177\/0961203310373782","article-title":"Transplantation of umbilical cord mesenchymal stem cells alleviates lupus nephritis in MRL\/lpr mice","volume":"19","author":"Gu","year":"2010","journal-title":"Lupus"},{"issue":"6","key":"10.1016\/j.intimp.2023.109699_b0265","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s00296-021-04796-5","article-title":"Acute liver injury as initial manifestation of systemic lupus erythematosus-induced myocarditis","volume":"41","author":"Neonaki","year":"2021","journal-title":"Rheumatol. Int."},{"issue":"11","key":"10.1016\/j.intimp.2023.109699_b0270","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.3899\/jrheum.080336","article-title":"Liver involvement in systemic lupus erythematosus: case review of 40 patients","volume":"35","author":"Chowdhary","year":"2008","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.intimp.2023.109699_b0275","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12878-016-0042-z","article-title":"Hypersplenism in liver disease and SLE revisited: current evidence supports an active rather than passive process","volume":"16","author":"Gemery","year":"2016","journal-title":"BMC Hematology"},{"issue":"1","key":"10.1016\/j.intimp.2023.109699_b0280","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s13287-021-02357-y","article-title":"Adipose-derived mesenchymal stem cells from obese mice prevent body weight gain and hyperglycemia","volume":"12","author":"Qi","year":"2021","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"10.1016\/j.intimp.2023.109699_b0285","doi-asserted-by":"crossref","first-page":"38","DOI":"10.15562\/bmj.v6i1.378","article-title":"Mesenchymal stem cell (MSC) as a potential cell therapy for immune related disease","volume":"6","author":"Kartiko","year":"2017","journal-title":"Bali Med J"},{"key":"10.1016\/j.intimp.2023.109699_b0290","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jconrel.2019.02.032","article-title":"Immunomodulatory properties of MSC-derived exosomes armed with high affinity aptamer toward mylein as a platform for reducing multiple sclerosis clinical score","volume":"299","author":"Shamili","year":"2019","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.intimp.2023.109699_b0295","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3390\/ijms18020244","article-title":"Mesenchymal stem cell therapy for inflammatory skin diseases: clinical potential and mode of action","volume":"18","author":"Shin","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2023.109699_b0300","series-title":"A single administration of human adipose tissue-derived mesenchymal stromal cells (MSC) induces durable and sustained long-term regulation of inflammatory response in experimental colitis","first-page":"139","author":"Alves","year":"2019"},{"issue":"11","key":"10.1016\/j.intimp.2023.109699_b0305","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/glia.20841","article-title":"Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis","volume":"57","author":"Bai","year":"2009","journal-title":"Glia"},{"key":"10.1016\/j.intimp.2023.109699_b0310","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.lfs.2019.01.052","article-title":"Novel approaches using mesenchymal stem cells for curing peripheral nerve injuries","volume":"221","author":"Yousefi","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.intimp.2023.109699_b0315","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jneuroim.2018.11.015","article-title":"Various strategies to improve efficacy of stem cell transplantation in multiple sclerosis: Focus on mesenchymal stem cells and neuroprotection","volume":"328","author":"Yousefi","year":"2019","journal-title":"J. Neuroimmunol."},{"issue":"5","key":"10.1016\/j.intimp.2023.109699_b0320","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/exd.12141","article-title":"Mesenchymal stem cell therapy in skin: why and what for?","volume":"22","author":"Khosrotehrani","year":"2013","journal-title":"Exp. Dermatol."},{"issue":"1","key":"10.1016\/j.intimp.2023.109699_b0325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-021-02586-1","article-title":"Transplantation of mesenchymal stem cells ameliorates systemic lupus erythematosus and upregulates B10 cells through TGF-\u03b21","volume":"12","author":"Chun","year":"2021","journal-title":"Stem Cell Res Ther"},{"issue":"8","key":"10.1016\/j.intimp.2023.109699_b0330","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1177\/0961203320928419","article-title":"Immunotherapeutic effects of allogeneic mesenchymal stem cells on systemic lupus erythematosus","volume":"29","author":"Liu","year":"2020","journal-title":"Lupus"},{"key":"10.1016\/j.intimp.2023.109699_b0335","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/7061408","article-title":"Prognostic factors for clinical response in systemic lupus erythematosus patients treated by allogeneic mesenchymal stem cells","volume":"2019","author":"Wen","year":"2019","journal-title":"Stem Cells Int."},{"issue":"5","key":"10.1016\/j.intimp.2023.109699_b0340","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nri3209","article-title":"Multipotent mesenchymal stromal cells and the innate immune system","volume":"12","author":"Le Blanc","year":"2012","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2023.109699_b0345","first-page":"1","article-title":"Mesenchymal stem cell therapy for acute radiation syndrome: innovative medical approaches in military medicine","volume":"2","author":"Eaton","year":"2015","journal-title":"Mil. Med. Res."},{"issue":"8","key":"10.1016\/j.intimp.2023.109699_b0350","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41581-018-0023-5","article-title":"Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases","volume":"14","author":"Shi","year":"2018","journal-title":"Nat. Rev. Nephrol."},{"issue":"1","key":"10.1016\/j.intimp.2023.109699_b0355","doi-asserted-by":"crossref","first-page":"e000199","DOI":"10.1136\/lupus-2016-000199","article-title":"Mouse models of lupus: what they tell us and what they don\u2019t","volume":"5","author":"Richard","year":"2018","journal-title":"Lupus science & medicine"},{"issue":"2","key":"10.1016\/j.intimp.2023.109699_b0360","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3727\/096368910X520056","article-title":"Therapeutic effects of umbilical cord blood-derived mesenchymal stem cell transplantation in experimental lupus nephritis","volume":"20","author":"Chang","year":"2011","journal-title":"Cell Transplant."},{"issue":"1","key":"10.1016\/j.intimp.2023.109699_b0365","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/art.33313","article-title":"Reversal of serologic, immunologic, and histologic dysfunction in mice with systemic lupus erythematosus by long-term serial adipose tissue\u2013derived mesenchymal stem cell transplantation","volume":"64","author":"Choi","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"8","key":"10.1016\/j.intimp.2023.109699_b0370","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1002\/art.1780340803","article-title":"Long-term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone only","volume":"34","author":"Steinberg","year":"1991","journal-title":"Arthritis & Rheumatism: Official Journal of the American College of Rheumatology"},{"issue":"sup75","key":"10.1016\/j.intimp.2023.109699_b0375","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3109\/03009748809096781","article-title":"Development of auto immunity in MRL\/Ipr mice and the effects of drugs on this murine disease","volume":"17","author":"Bartlett","year":"1988","journal-title":"Scand. J. Rheumatol."},{"issue":"6","key":"10.1016\/j.intimp.2023.109699_b0380","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.4049\/jimmunol.173.6.4171","article-title":"Modulation of renal disease in MRL\/lpr mice by suberoylanilide hydroxamic acid","volume":"173","author":"Reilly","year":"2004","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2023.109699_b0385","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1124\/jpet.108.142711","article-title":"Anti-Ccl2 Spiegelmer permits 75% dose reduction of cyclophosphamide to control diffuse proliferative lupus nephritis and pneumonitis in MRL-Fas (lpr) mice","volume":"328","author":"Kulkarni","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"9","key":"10.1016\/j.intimp.2023.109699_b0390","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.it.2009.06.003","article-title":"Induction of autoimmunity by pristane and other naturally occurring hydrocarbons","volume":"30","author":"Reeves","year":"2009","journal-title":"Trends Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2023.109699_b0395","first-page":"93","article-title":"Acute and subacute toxicity study of the ethanol crude extract of Leptadenia hastata plant (Pers.) Decne. in Wistar rats","volume":"15","author":"Tata","year":"2019","journal-title":"Niger. J. Pharm. Res."},{"issue":"1","key":"10.1016\/j.intimp.2023.109699_b0400","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/0023677219883319","article-title":"Defining body-weight reduction as a humane endpoint: a critical appraisal","volume":"54","author":"Talbot","year":"2020","journal-title":"Lab. Anim"},{"issue":"7","key":"10.1016\/j.intimp.2023.109699_b0405","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.molmed.2017.05.006","article-title":"Pathogenesis of human systemic lupus erythematosus: a cellular perspective","volume":"23","author":"Moulton","year":"2017","journal-title":"Trends Mol. Med."},{"issue":"6","key":"10.1016\/j.intimp.2023.109699_b0410","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.7150\/ijms.51117","article-title":"Elevated Creatinine Clearance in Lupus Nephritis patients with Normal Creatinine","volume":"18","author":"Wang","year":"2021","journal-title":"Int. J. Med. Sci."},{"issue":"7","key":"10.1016\/j.intimp.2023.109699_b0415","doi-asserted-by":"crossref","first-page":"928","DOI":"10.3390\/biom11070928","article-title":"Clinical and Immunological Biomarkers for Systemic Lupus Erythematosus","volume":"11","author":"Yu","year":"2021","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.intimp.2023.109699_b0420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2431-13-179","article-title":"Systemic lupus erythematosus and granulomatous lymphadenopathy","volume":"13","author":"Shrestha","year":"2013","journal-title":"BMC Pediatr."},{"issue":"3","key":"10.1016\/j.intimp.2023.109699_b0425","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/ki.1988.186","article-title":"Determinants of immune complex-mediated glomerulonephritis","volume":"34","author":"Fries","year":"1988","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/j.intimp.2023.109699_b0430","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1038\/ki.1997.475","article-title":"Progression of renal damage in human glomerulonephritides: Is there sleight of hand in winning the game?","volume":"52","author":"Schena","year":"1997","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.intimp.2023.109699_b0435","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-019-1538-9","article-title":"Efficacy of mesenchymal stem cells in animal models of lupus nephritis: a meta-analysis","volume":"11","author":"Zhou","year":"2020","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.intimp.2023.109699_b0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2019.104472","article-title":"Variance of body and organ weights in 28-day studies in mice","volume":"108","author":"Marxfeld","year":"2019","journal-title":"Regul. Toxicol. Pharm."},{"key":"10.1016\/j.intimp.2023.109699_b0445","doi-asserted-by":"crossref","unstructured":"Aringer, M., et al., A glimpse into the future of systemic lupus erythematosus. Ther Adv Musculoskelet Dis, 2022. 14: p. 1759720x221086719.","DOI":"10.1177\/1759720X221086719"},{"issue":"12","key":"10.1016\/j.intimp.2023.109699_b0620","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.3727\/096368912X658692","article-title":"Allogenic mesenchymal stem cell transplantation ameliorates nephritis in lupus mice via inhibition of B-cell activation","volume":"22","author":"Ma","year":"2013","journal-title":"Cell Transplant."},{"issue":"2","key":"10.1016\/j.intimp.2023.109699_b0450","first-page":"124","article-title":"Protective Effect of Quercetin Against Oxidative Stress-induced Toxicity Associated With Doxorubicin and Cyclophosphamide in Rat Kidney and Liver Tissue","volume":"11","author":"Kocahan","year":"2017","journal-title":"Iran J Kidney Dis"},{"issue":"1","key":"10.1016\/j.intimp.2023.109699_b0455","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s12011-017-1231-8","article-title":"Protective Effects of Selenium on Cyclophosphamide-Induced Oxidative Stress and Kidney Injury","volume":"185","author":"Gunes","year":"2018","journal-title":"Biol. Trace Elem. Res."},{"issue":"6","key":"10.1016\/j.intimp.2023.109699_b0460","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/14653240310003611","article-title":"Immunomodulatory effects of fetal and adult mesenchymal stem cells","volume":"5","author":"Le Blanc","year":"2003","journal-title":"Cytotherapy"},{"issue":"5","key":"10.1016\/j.intimp.2023.109699_b9005","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1002\/eji.200425405","article-title":"Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway","volume":"35","author":"Augello","year":"2005","journal-title":"Eur. J. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2023.109699_b9010","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.3390\/cells8121491","article-title":"Mesenchymal stem\/stromal cells derived from dental tissues: A comparative in vitro evaluation of their immunoregulatory properties against T cells","volume":"8","author":"De la Rosa-Ruiz","year":"2019","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.intimp.2023.109699_b0655","doi-asserted-by":"crossref","first-page":"302","DOI":"10.4049\/jimmunol.0902007","article-title":"Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype","volume":"185","author":"Ghannam","year":"2010","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2023.109699_b0465","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1124\/jpet.108.142711","article-title":"Anti-Ccl2 Spiegelmer permits 75% dose reduction of cyclophosphamide to control diffuse proliferative lupus nephritis and pneumonitis in MRL-Fas(lpr) mice","volume":"328","author":"Kulkarni","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"10.1016\/j.intimp.2023.109699_b0470","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/stem.2779","article-title":"Immunomodulation by therapeutic mesenchymal stromal cells (MSC) is triggered through phagocytosis of MSC by monocytic cells","volume":"36","author":"de Witte","year":"2018","journal-title":"Stem Cells"},{"key":"10.1016\/j.intimp.2023.109699_b0475","doi-asserted-by":"crossref","unstructured":"Mesenchymal Stem Cell (MSC)-Derived Extracellular Vesicles: Potential Therapeutics as MSC Trophic Mediators in Regenerative Medicine. Anatomical Record, 2020. 303(6): p. 1735-1742.","DOI":"10.1002\/ar.24186"},{"issue":"6","key":"10.1016\/j.intimp.2023.109699_b0480","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.jhep.2018.01.030","article-title":"Mesenchymal stromal cell therapy for liver diseases","volume":"68","author":"Alfaifi","year":"2018","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.intimp.2023.109699_b0485","first-page":"501","article-title":"Morphology of the bone marrow, spleen and liver during hematopoietic cell mobilization with cyclophosphamide in mice","volume":"46","author":"Barcew","year":"2008","journal-title":"Folia Histochem Cytobiol"},{"issue":"6","key":"10.1016\/j.intimp.2023.109699_b0490","doi-asserted-by":"crossref","DOI":"10.4314\/ejhs.v28i6.5","article-title":"Toxic effects of different doses of cyclophosphamide on liver and kidney tissue in Swiss albino mice: a histopathological study","volume":"28","author":"Bhat","year":"2018","journal-title":"Ethiop. J. Health Sci."},{"issue":"7","key":"10.1016\/j.intimp.2023.109699_b0495","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1177\/0960327120909880","article-title":"Cyclophosphamide induces a significant increase in iron content in the liver and spleen of mice","volume":"39","author":"Sheng","year":"2020","journal-title":"Hum. Exp. Toxicol."},{"issue":"4","key":"10.1016\/j.intimp.2023.109699_b0500","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nri3173","article-title":"The molecular basis of the memory T cell response: differential gene expression and its epigenetic regulation","volume":"12","author":"Weng","year":"2012","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2023.109699_b0505","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1084\/jem.188.5.985","article-title":"Interleukin 6 dependence of anti-DNA antibody production: evidence for two pathways of autoantibody formation in pristane-induced lupus","volume":"188","author":"Richards","year":"1998","journal-title":"J. Exp. Med."},{"issue":"8","key":"10.1016\/j.intimp.2023.109699_b0510","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1172\/JCI80883","article-title":"Intrathecal bone marrow stromal cells inhibit neuropathic pain via TGF-\u03b2 secretion","volume":"125","author":"Chen","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.intimp.2023.109699_b0515","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.3349\/ymj.2017.58.5.1031","article-title":"Immune tolerance of human dental pulp-derived mesenchymal stem cells mediated by CD4+ CD25+ FoxP3+ regulatory T-cells and induced by TGF-\u03b21 and IL-10","volume":"58","author":"Hong","year":"2017","journal-title":"Yonsei Med. J."},{"issue":"1","key":"10.1016\/j.intimp.2023.109699_b0520","article-title":"Revealing the decrease of indoleamine 2,3-dioxygenase as a major constituent for B cells survival post-mesenchymal stem cells co-cultured with peripheral blood mononuclear cell (PBMC) of systemic lupus erythematosus (SLE) patients","volume":"19","author":"Masyithah Darlan","year":"2022","journal-title":"Med Glas (Zenica)"},{"key":"10.1016\/j.intimp.2023.109699_b0525","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev-immunol-032713-120257","article-title":"TGF-\u03b2 activation and function in immunity","volume":"32","author":"Travis","year":"2014","journal-title":"Annu. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2023.109699_b0530","doi-asserted-by":"crossref","first-page":"6425","DOI":"10.1002\/jcp.26429","article-title":"Macrophage plasticity, polarization, and function in health and disease","volume":"233","author":"Shapouri-Moghaddam","year":"2018","journal-title":"J. Cell. Physiol."},{"issue":"3","key":"10.1016\/j.intimp.2023.109699_b0535","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1634\/stemcells.2004-0258","article-title":"A new strategy for treatment of malignant tumor: intra-bone marrow-bone marrow transplantation plus CD4- donor lymphocyte infusion","volume":"23","author":"Suzuki","year":"2005","journal-title":"Stem cells (Dayton, Ohio)"},{"issue":"5","key":"10.1016\/j.intimp.2023.109699_b0545","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/cmi.2015.89","article-title":"The regulation of the Treg\/Th17 balance by mesenchymal stem cells in human systemic lupus erythematosus","volume":"14","author":"Wang","year":"2017","journal-title":"Cell. Mol. Immunol."},{"issue":"25","key":"10.1016\/j.intimp.2023.109699_b0550","doi-asserted-by":"crossref","first-page":"38164","DOI":"10.18632\/oncotarget.9416","article-title":"Quantitation of TGF-\u03b2 proteins in mouse tissues shows reciprocal changes in TGF-\u03b21 and TGF-\u03b23 in normal vs neoplastic mammary epithelium","volume":"7","author":"Flanders","year":"2016","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.intimp.2023.109699_b0555","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.humimm.2009.01.018","article-title":"The tolerogenic peptide hCDR1 downregulates pathogenic cytokines and apoptosis and upregulates immunosuppressive molecules and regulatory T cells in peripheral blood mononuclear cells of lupus patients","volume":"70","author":"Sthoeger","year":"2009","journal-title":"Hum. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2023.109699_b0560","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1093\/rheumatology\/ker116","article-title":"Recovery of the immune balance between Th17 and regulatory T cells as a treatment for systemic lupus erythematosus","volume":"50","author":"Yang","year":"2011","journal-title":"Rheumatology"},{"issue":"12","key":"10.1016\/j.intimp.2023.109699_b0565","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1084\/jem.20030152","article-title":"Conversion of peripheral CD4+ CD25\u2212 naive T cells to CD4+ CD25+ regulatory T cells by TGF-\u03b2 induction of transcription factor Foxp3","volume":"198","author":"Chen","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2023.109699_b0570","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.3389\/fimmu.2018.02666","article-title":"Third-party allogeneic mesenchymal stromal cells prevent rejection in a pre-sensitized high-risk model of corneal transplantation","author":"Lohan","year":"2018","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2023.109699_b0575","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1089\/scd.2011.0157","article-title":"The role of mouse mesenchymal stem cells in differentiation of naive T-cells into anti-inflammatory regulatory T-cell or proinflammatory helper T-cell 17 population","volume":"21","author":"Svobodova","year":"2012","journal-title":"Stem Cells Dev."},{"issue":"11","key":"10.1016\/j.intimp.2023.109699_b0580","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1002\/eji.200636459","article-title":"FOXP3+ regulatory T cells: current controversies and future perspectives","volume":"36","author":"Banham","year":"2006","journal-title":"Eur. J. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2023.109699_b0585","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jaut.2006.06.005","article-title":"Regulatory T cells in patients with systemic lupus erythematosus","volume":"27","author":"Alvarado-S\u00e1nchez","year":"2006","journal-title":"J. Autoimmun."},{"issue":"9","key":"10.1016\/j.intimp.2023.109699_b0590","first-page":"490","article-title":"The association among serum levels of vitamin D, TGF-\u03b2\/IL-6 balance and Treg\/Th17 balance in systemic lupus erythematosus patients in Indonesia","volume":"2","author":"Handono","year":"2013","journal-title":"International Journal of Biochemistry and Biotechnology"},{"key":"10.1016\/j.intimp.2023.109699_b0595","article-title":"Gastric Cancer Stem Cells Effect on Th17\/Treg Balance; A Bench to Beside Perspective. Frontiers","volume":"9","author":"Rezalotfi","year":"2019","journal-title":"Oncology"},{"issue":"1","key":"10.1016\/j.intimp.2023.109699_b0600","article-title":"Association between the low levels of vitamin D and Treg function in systemic lupus erythematosus patients","volume":"45","author":"Handono","year":"2016","journal-title":"Acta Med. Indones."},{"issue":"6","key":"10.1016\/j.intimp.2023.109699_b0605","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.2353\/ajpath.2008.080314","article-title":"Increased Foxp3+ CD4+ regulatory T cells with intact suppressive activity but altered cellular localization in murine lupus","volume":"173","author":"Abe","year":"2008","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.intimp.2023.109699_b0610","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3727\/096368913X664577","article-title":"Combination cell therapy using mesenchymal stem cells and regulatory T-cells provides a synergistic immunomodulatory effect associated with reciprocal regulation of TH1\/TH2 and th17\/treg cells in a murine acute graft-versus-host disease model","volume":"23","author":"Lim","year":"2014","journal-title":"Cell Transplant."},{"issue":"5","key":"10.1016\/j.intimp.2023.109699_b0615","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.3349\/ymj.2017.58.5.1031","article-title":"Immune Tolerance of Human Dental Pulp-Derived Mesenchymal Stem Cells Mediated by CD4+CD25+FoxP3+ Regulatory T-Cells and Induced by TGF-\u03b21 and IL-10","volume":"58","author":"Hong","year":"2017","journal-title":"Yonsei Med. J."},{"issue":"8","key":"10.1016\/j.intimp.2023.109699_b0625","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1007\/s12015-022-10397-x","article-title":"Cross Talk between Mesenchymal Stem\/Stromal Cells and Innate Immunocytes Concerning Lupus Disease","volume":"18","author":"Mahmoudi","year":"2022","journal-title":"Stem Cell Rev. Rep."},{"issue":"43","key":"10.1016\/j.intimp.2023.109699_b0630","doi-asserted-by":"crossref","first-page":"18575","DOI":"10.1073\/pnas.1000400107","article-title":"Cell-permeable Foxp3 protein alleviates autoimmune disease associated with inflammatory bowel disease and allergic airway inflammation","volume":"107","author":"Choi","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2023.109699_b0635","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3109\/08923973.2014.968255","article-title":"Assessment of 1, 25-dihydroxyvitamin D3 effects on Treg cells in a mouse model of systemic lupus erythematosus","volume":"37","author":"Lavi Arab","year":"2015","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.intimp.2023.109699_b0640","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.tox.2014.07.011","article-title":"Di-(2-ethylhexyl) phthalate adjuvantly induces imbalanced humoral immunity in ovalbumin-sensitized BALB\/c mice ascribing to T follicular helper cells hyperfunction","volume":"324","author":"Han","year":"2014","journal-title":"Toxicology"},{"issue":"7","key":"10.1016\/j.intimp.2023.109699_b0645","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.3390\/cells9071660","article-title":"Mechanisms behind the immunoregulatory dialogue between mesenchymal stem cells and Th17 cells","volume":"9","author":"Terraza-Aguirre","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.intimp.2023.109699_b0650","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/823085","article-title":"Balance between regulatory T and Th17 cells in systemic lupus erythematosus: the old and the new","volume":"2012","author":"Alunno","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.intimp.2023.109699_b0660","doi-asserted-by":"crossref","first-page":"E134","DOI":"10.3390\/molecules22010134","article-title":"Therapeutic Potential of Targeting the Th17\/Treg Axis in Autoimmune Disorders","volume":"22","author":"Fasching","year":"2017","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"1\u20132","key":"10.1016\/j.intimp.2023.109699_b0665","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.imlet.2010.09.006","article-title":"Opposing effect of mesenchymal stem cells on Th1 and Th17 cell polarization according to the state of CD4+ T cell activation","volume":"135","author":"Carri\u00f3n","year":"2011","journal-title":"Immunol. Lett."},{"issue":"1","key":"10.1016\/j.intimp.2023.109699_b0670","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-019-1307-9","article-title":"Mesenchymal stem cell repression of Th17 cells is triggered by mitochondrial transfer","volume":"10","author":"Luz-Crawford","year":"2019","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"10.1016\/j.intimp.2023.109699_b0675","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2174\/157488811794480762","article-title":"Bone marrow mesenchymal stem cells: agents of immunomodulation and neuroprotection","volume":"6","author":"Kassis","year":"2011","journal-title":"Curr. Stem Cell Res. Ther."},{"issue":"3","key":"10.1016\/j.intimp.2023.109699_b0680","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.clim.2013.01.009","article-title":"Hematopoetic and mesenchymal stem cell transplantation in the treatment of refractory systemic lupus erythematosus\u2014Where are we now?","volume":"148","author":"Collins","year":"2013","journal-title":"Clin. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2023.109699_b0685","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar4520","article-title":"Umbilical cord mesenchymal stem cell transplantation in active and refractory systemic lupus erythematosus: a multicenter clinical study","volume":"16","author":"Wang","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.intimp.2023.109699_b0690","article-title":"Imbalance between Th17 and regulatory T cells in patients with systemic lupus erythematosus combined EBV\/CMV viraemia","author":"Su","year":"2019","journal-title":"Clin. Exp. Rheumatol."},{"issue":"12","key":"10.1016\/j.intimp.2023.109699_b0695","first-page":"7627","article-title":"Human gingiva tissue-derived MSC ameliorates immune-mediated bone marrow failure of aplastic anemia via suppression of Th1 and Th17 cells and enhancement of CD4+ Foxp3+ regulatory T cells differentiation","volume":"11","author":"Zhao","year":"2019","journal-title":"Am. J. Transl. Res."},{"issue":"3","key":"10.1016\/j.intimp.2023.109699_b0700","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s12015-014-9558-4","article-title":"Amniotic membrane mesenchymal cells-derived factors skew T cell polarization toward Treg and downregulate Th1 and Th17 cells subsets","volume":"11","author":"Pianta","year":"2015","journal-title":"Stem Cell Rev. Rep."},{"issue":"11","key":"10.1016\/j.intimp.2023.109699_b0705","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s10067-010-1510-7","article-title":"The imbalance between regulatory and IL-17-secreting CD4+ T cells in lupus patients","volume":"29","author":"Ma","year":"2010","journal-title":"Clin. Rheumatol."},{"issue":"6","key":"10.1016\/j.intimp.2023.109699_b0710","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/rheumatology\/ken108","article-title":"Altered frequency and migration capacity of CD4+ CD25+ regulatory T cells in systemic lupus erythematosus","volume":"47","author":"Lee","year":"2008","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.intimp.2023.109699_b0715","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00403-008-0891-9","article-title":"CD4+ CD25+ regulatory T cells in human lupus erythematosus","volume":"301","author":"Kuhn","year":"2009","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.intimp.2023.109699_b0720","series-title":"Immune-Mediated Diseases","first-page":"113","article-title":"Reduced number and function of CD4+ CD25 high FoxP3+ regulatory T cells in patients with systemic lupus erythematosus","author":"Lyssuk","year":"2007"},{"issue":"6","key":"10.1016\/j.intimp.2023.109699_b0725","doi-asserted-by":"crossref","first-page":"9778","DOI":"10.1002\/jcp.27663","article-title":"Amelioration of regulatory T cells by Lactobacillus delbrueckii and Lactobacillus rhamnosus in pristane-induced lupus mice model","volume":"234","author":"Khorasani","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"5","key":"10.1016\/j.intimp.2023.109699_b0730","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.4049\/jimmunol.0900385","article-title":"The role of IL-23\/IL-17 axis in lupus nephritis","volume":"183","author":"Zhang","year":"2009","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2023.109699_b0735","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s11684-015-0388-9","article-title":"Th17 cells in autoimmune diseases","volume":"9","author":"Han","year":"2015","journal-title":"Frontiers of Medicine"},{"issue":"4","key":"10.1016\/j.intimp.2023.109699_b0740","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.kint.2017.08.030","article-title":"IL-17A improves the efficacy of mesenchymal stem cells in ischemic-reperfusion renal injury by increasing Treg percentages by the COX-2\/PGE2 pathway","volume":"93","author":"Bai","year":"2018","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/j.intimp.2023.109699_b9025","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00005-015-0344-z","article-title":"The role of IL-17 and Th17 lymphocytes in autoimmune diseases","volume":"63","author":"Tabarkiewicz","year":"2015","journal-title":"Archivum immunologiae et therapiae experimentalis"},{"key":"10.1016\/j.intimp.2023.109699_b0750","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6961052","article-title":"Mesenchymal stem cells alleviate moderate-to-severe psoriasis by reducing the production of type I interferon (IFN-I) by plasmacytoid dendritic cells (pDCs)","author":"Chen","year":"2019","journal-title":"Stem Cells Int."},{"issue":"11","key":"10.1016\/j.intimp.2023.109699_b0755","doi-asserted-by":"crossref","first-page":"5484","DOI":"10.4049\/jimmunol.158.11.5484","article-title":"IFN-gamma is essential for the development of autoimmune glomerulonephritis in MRL\/Ipr mice","volume":"158","author":"Haas","year":"1997","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2023.109699_b0760","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.it.2011.11.004","article-title":"How mesenchymal stem cells interact with tissue immune responses","volume":"33","author":"Shi","year":"2012","journal-title":"Trends Immunol."},{"key":"10.1016\/j.intimp.2023.109699_b0765","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fimmu.2019.00043","article-title":"Past, Present, and Future of Regulatory T Cell Therapy in Transplantation and Autoimmunity","volume":"10","author":"Romano","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.intimp.2023.109699_b0770","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/scrt75","article-title":"Mesenchymal stem cell effects on T-cell effector pathways","volume":"2","author":"Duffy","year":"2011","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.intimp.2023.109699_b0775","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1756-8722-5-19","article-title":"Clinical applications of mesenchymal stem cells","volume":"5","author":"Wang","year":"2012","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.intimp.2023.109699_b0780","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21608\/ejhm.2010.17362","article-title":"Assessment of Proinflammatory Th1 Cytokines (IL18-IFN) and Th2 Cytokine (IL13) Concentrations in patients with Autoimmune Rheumatic Diseases (Systemic Lupus Erythematosus, Rheumatoid Artharitis and Systemic Sclerosis)","volume":"38","author":"Sultan","year":"2010","journal-title":"Egypt. J. Hosp. Med."},{"key":"10.1016\/j.intimp.2023.109699_b0785","doi-asserted-by":"crossref","first-page":"550","DOI":"10.3389\/fimmu.2015.00550","article-title":"Pathogenic Inflammation and Its Therapeutic Targeting in Systemic Lupus Erythematosus","volume":"6","author":"Gottschalk","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.intimp.2023.109699_b0790","unstructured":"Biedermann, T. and M. R\u00f6cken. Pro- and Anti-inflammatory Effects of IL-4: From Studies in Mice to Therapy of Autoimmune Diseases in Humans. in Animal Models of T Cell-Mediated Skin Diseases. 2005. Berlin, Heidelberg: Springer Berlin Heidelberg."},{"issue":"17","key":"10.1016\/j.intimp.2023.109699_b0795","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1089\/scd.2015.0021","article-title":"Transplantation of adipose tissue-derived mesenchymal stem cells prevents the development of lupus dermatitis","volume":"24","author":"Choi","year":"2015","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.intimp.2023.109699_b0800","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.3389\/fimmu.2018.02666","article-title":"Third-Party Allogeneic Mesenchymal Stromal Cells Prevent Rejection in a Pre-sensitized High-Risk Model of Corneal Transplantation","volume":"9","author":"Lohan","year":"2018","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.intimp.2023.109699_b0805","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/stem.656","article-title":"Bone marrow-derived mesenchymal stromal cells inhibit Th2-mediated allergic airways inflammation in mice","volume":"29","author":"Goodwin","year":"2011","journal-title":"Stem Cells"},{"issue":"11","key":"10.1016\/j.intimp.2023.109699_b0810","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.5966\/sctm.2015-0243","article-title":"Human mesenchymal stem cells impact Th17 and Th1 responses through a prostaglandin E2 and myeloid-dependent mechanism","volume":"5","author":"Rozenberg","year":"2016","journal-title":"Stem Cells Transl. Med."},{"issue":"8","key":"10.1016\/j.intimp.2023.109699_b0815","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nrneph.2017.100","article-title":"Mesenchymal stromal cells in lupus nephritis","volume":"13","author":"Fibbe","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.intimp.2023.109699_b0820","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/5584_2018_212","article-title":"Therapeutic Applications of Mesenchymal Stem Cells for Systemic Lupus Erythematosus","volume":"1089","author":"Xu","year":"2018","journal-title":"Advances in Experimental Medicine and Biology"},{"issue":"2","key":"10.1016\/j.intimp.2023.109699_b0825","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.imlet.2007.04.001","article-title":"IFN-gamma and TNF-alpha differentially regulate immunomodulation by murine mesenchymal stem cells","volume":"110","author":"English","year":"2007","journal-title":"Immunol Lett"},{"issue":"2","key":"10.1016\/j.intimp.2023.109699_b0830","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jcyt.2013.11.008","article-title":"Human mesenchymal stromal cells transiently increase cytokine production by activated T cells before suppressing T-cell proliferation: effect of interferon-\u03b3 and tumor necrosis factor-\u03b1 stimulation","volume":"16","author":"Cuerquis","year":"2014","journal-title":"Cytotherapy"},{"issue":"4","key":"10.1016\/j.intimp.2023.109699_b0835","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/s12015-010-9178-6","article-title":"Inflammatory cytokine induced regulation of superoxide dismutase 3 expression by human mesenchymal stem cells","volume":"6","author":"Kemp","year":"2010","journal-title":"Stem Cell Rev Rep"},{"issue":"4","key":"10.1016\/j.intimp.2023.109699_b0840","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/scrt75","article-title":"Mesenchymal stem cell effects on T-cell effector pathways","volume":"2","author":"Duffy","year":"2011","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"10.1016\/j.intimp.2023.109699_b0845","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.stem.2007.11.014","article-title":"Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide","volume":"2","author":"Ren","year":"2008","journal-title":"Cell Stem Cell"},{"issue":"3","key":"10.1016\/j.intimp.2023.109699_b9015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.21315\/mjms2018.25.3.3","article-title":"Regulatory T cells compensation failure cause the dysregulation of immune response in pristane induced lupus mice model","volume":"25","author":"Kalim","year":"2018","journal-title":"Malaysian J. Med. Sci. MJMS"},{"issue":"5","key":"10.1016\/j.intimp.2023.109699_b9020","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.4049\/jimmunol.0900385","article-title":"The role of IL-23\/IL-17 axis in lupus nephritis","volume":"183","author":"Zhang","year":"2009","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2023.109699_b0850","doi-asserted-by":"crossref","first-page":"4","DOI":"10.55563\/clinexprheumatol\/nolysy","article-title":"One year in review 2022: systemic lupus erythematosus","volume":"40","author":"Zucchi","year":"2022","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"10.1016\/j.intimp.2023.109699_b0855","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1186\/ar2964","article-title":"Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus","volume":"12","author":"Shah","year":"2010","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"10.1016\/j.intimp.2023.109699_b0860","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/art.24499","article-title":"Th17 and natural Treg cell population dynamics in systemic lupus erythematosus","volume":"60","author":"Yang","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.intimp.2023.109699_b0745","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00005-015-0344-z","article-title":"The role of IL-17 and Th17 lymphocytes in autoimmune diseases","volume":"63","author":"Tabarkiewicz","year":"2015","journal-title":"Arch. Immunol. Ther. Exp. (Warsz)"},{"key":"10.1016\/j.intimp.2023.109699_b0865","doi-asserted-by":"crossref","first-page":"6961052","DOI":"10.1155\/2019\/6961052","article-title":"Mesenchymal Stem Cells Alleviate Moderate-to-Severe Psoriasis by Reducing the Production of Type I Interferon (IFN-I) by Plasmacytoid Dendritic Cells (pDCs)","volume":"2019","author":"Chen","year":"2019","journal-title":"Stem Cells Int"},{"key":"10.1016\/j.intimp.2023.109699_b0870","first-page":"1","article-title":"Modulation of Mesenchymal Stem Cells-Mediated Adaptive Immune Effectors\u2019 Repertoire in the Recovery of Systemic Lupus Erythematosus","author":"Hoseinzadeh","year":"2022","journal-title":"Stem Cell Rev. Rep."},{"issue":"8","key":"10.1016\/j.intimp.2023.109699_b0875","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1089\/ten.2006.12.2263","article-title":"Human mesenchymal stem cells induce T cell anergy and downregulate T cell allo-responses via the TH2 pathway: relevance to tissue engineering human heart valves","volume":"12","author":"Batten","year":"2006","journal-title":"Tissue Eng."},{"key":"10.1016\/j.intimp.2023.109699_b0880","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.2147\/DDDT.S114501","article-title":"Methyl salicylate 2-O-\u03b2-d-lactoside alleviates the pathological progression of pristane-induced systemic lupus erythematosus-like disease in mice via suppression of inflammatory response and signal transduction","volume":"10","author":"He","year":"2016","journal-title":"Drug Des. Devel. Ther."},{"issue":"4","key":"10.1016\/j.intimp.2023.109699_b0885","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.gpb.2015.09.001","article-title":"Autoantigen microarray for high-throughput autoantibody profiling in systemic lupus erythematosus","volume":"13","author":"Zhu","year":"2015","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"10.1016\/j.intimp.2023.109699_b0890","doi-asserted-by":"crossref","first-page":"D1369","DOI":"10.2741\/Hoffman","article-title":"T cells in the pathogenesis of systemic lupus erythematosus","volume":"6","author":"Hoffman","year":"2001","journal-title":"Front Biosci"},{"issue":"1","key":"10.1016\/j.intimp.2023.109699_b0895","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1600-065X.1999.tb01310.x","article-title":"The central and multiple roles of B cells in lupus pathogenesis","volume":"169","author":"Chan","year":"1999","journal-title":"Immunol. Rev."},{"issue":"1","key":"10.1016\/j.intimp.2023.109699_b0900","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep38237","article-title":"Mesenchymal stem cell transplantation can restore lupus disease-associated miRNA expression and Th1\/Th2 ratios in a murine model of SLE","volume":"6","author":"Choi","year":"2016","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.intimp.2023.109699_b0905","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.stemcr.2017.06.020","article-title":"Activated tissue-resident mesenchymal stromal cells regulate natural killer cell immune and tissue-regenerative function","volume":"9","author":"Petri","year":"2017","journal-title":"Stem Cell Rep."},{"issue":"2","key":"10.1016\/j.intimp.2023.109699_b0910","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jcyt.2015.10.011","article-title":"Mesenchymal stromal cells and immunomodulation: a gathering of regulatory immune cells","volume":"18","author":"Najar","year":"2016","journal-title":"Cytotherapy"},{"key":"10.1016\/j.intimp.2023.109699_b0915","doi-asserted-by":"crossref","first-page":"8253","DOI":"10.7150\/thno.37351","article-title":"Mesenchymal stem cell transplantation alleviates experimental Sj\u00f6gren's syndrome through IFN-\u03b2\/IL-27 signaling axis","volume":"9","author":"Yao","year":"2019","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.intimp.2023.109699_b0920","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1046\/j.1365-2249.2000.01174.x","article-title":"Complex pattern of Th1 and Th2 activation with a preferential increase of autoreactive Th1 cells in BALB\/c mice with proteoglycan (aggrecan)-induced arthritis","volume":"120","author":"Hollo","year":"2000","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2023.109699_b0925","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/icb.2012.56","article-title":"Mechanisms of mesenchymal stromal cell immunomodulation","volume":"91","author":"English","year":"2013","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.intimp.2023.109699_b0930","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.intimp.2017.01.008","article-title":"Adipose-derived stem cells ameliorate renal interstitial fibrosis through inhibition of EMT and inflammatory response via TGF-\u03b21 signaling pathway","volume":"44","author":"Song","year":"2017","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2023.109699_b0935","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13075-016-0979-0","article-title":"Human embryonic stem cell-derived mesenchymal stromal cells ameliorate collagen-induced arthritis by inducing host-derived indoleamine 2,3 dioxygenase","volume":"18","author":"Gonzalo-Gil","year":"2016","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.intimp.2023.109699_b0940","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1681\/ASN.2019050545","article-title":"Additive therapeutic effects of mesenchymal stem cells and IL-37 for systemic lupus erythematosus","volume":"31","author":"Xu","year":"2020","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.intimp.2023.109699_b0945","first-page":"535","article-title":"Increased IL-18 in patients with systemic lupus erythematosus: Relations with Th-1, Th-2, pro-inflammatory cytokines and disease activity. IL-18 is a marker of disease activity but does not correlate with pro-inflammatory cytokines","volume":"20","author":"Amerio","year":"2002","journal-title":"Clin. Exp. Rheumatol."},{"issue":"20","key":"10.1016\/j.intimp.2023.109699_b0950","doi-asserted-by":"crossref","first-page":"5519","DOI":"10.7150\/thno.27674","article-title":"Injection of adipose-derived stromal cells in the knee of patients with severe osteoarthritis has a systemic effect and promotes an anti-inflammatory phenotype of circulating immune cells","volume":"8","author":"Pers","year":"2018","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.intimp.2023.109699_b0955","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jgm.1531","article-title":"Transplantation of CTLA4Ig gene-transduced adipose tissue-derived mesenchymal stem cells reduces inflammatory immune response and improves Th1\/Th2 balance in experimental autoimmune thyroiditis","volume":"13","author":"Choi","year":"2011","journal-title":"J Gene Med"},{"issue":"6","key":"10.1016\/j.intimp.2023.109699_b0960","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.3727\/096368915X689442","article-title":"Comparative efficacies of long-term serial transplantation of syngeneic, allogeneic, xenogeneic, or CTLA4Ig-overproducing xenogeneic adipose tissue-derived mesenchymal stem cells on murine systemic lupus erythematosus","volume":"25","author":"Choi","year":"2016","journal-title":"Cell Transplant."},{"issue":"9","key":"10.1016\/j.intimp.2023.109699_b0965","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1517\/13543784.9.9.2147","article-title":"CTLA4-Ig: a novel immunosuppressive agent","volume":"9","author":"Najafian","year":"2000","journal-title":"Expert Opin. Invest. Drugs"},{"issue":"9","key":"10.1016\/j.intimp.2023.109699_b0970","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1172\/JCI5857","article-title":"CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris","volume":"103","author":"Abrams","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2023.109699_b0975","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.toxrep.2015.02.009","article-title":"Sub-chronic exposure to fipronil induced oxidative stress, biochemical and histopathological changes in the liver and kidney of male albino rats","volume":"2","author":"Mossa","year":"2015","journal-title":"Toxicol. Rep."},{"issue":"3","key":"10.1016\/j.intimp.2023.109699_b0980","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1136\/jnnp.42.3.226","article-title":"Wernicke's encephalopathy: a more common disease than realised. A neuropathological study of 51 cases","volume":"42","author":"Harper","year":"1979","journal-title":"J. Neurol. Neurosurg. Psychiatry"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692300022X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692300022X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:54:28Z","timestamp":1761587668000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156757692300022X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":201,"alternative-id":["S156757692300022X"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.109699","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dysregulated balance in Th17\/Treg axis of Pristane-induced lupus mouse model, are mesenchymal stem cells therapeutic?","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.109699","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109699"}}